News

UC Riverside-led study on innate immune system may lead to new treatments for patients with neuroHIV

CCHFV poses a threat to U.S. military personnel and hospital staff as well as residents of a growing number of countries, says UC Riverside biomedical scientist

Strategy developed by UC Riverside-led research team speeds up production of antibodies against COVID-19

$13.7M grant from National Cancer Institute will support several projects on breast and pancreatic cancers

UC Riverside biomedical scientists say the cells are like M cells in the gut and airways

Has the news about an Australian woman with a living, wriggling roundworm in her brain got you spooked? After experiencing abdominal pain and night sweats that developed into forgetfulness and depression, the 64-year-old woman was sent to a hospital. An MRI scan did reveal something unusual in her brain, but...

Exposure to environmental chemicals, including those in common plastic products, has been linked with an increased risk of cardiovascular disease, or CVD, the leading cause of death worldwide. According to the World Health Organization, 17.9 million people died from CVDs in 2019. Changcheng Zhou, a professor of biomedical sciences in...

UC Riverside mouse study describes mechanisms underlying sex differences for obesity

Inflammatory bowel disease, or IBD, describes Crohn’s disease and ulcerative colitis, two chronic diseases that cause inflammation in the intestines. IBD, which affects about 3 million adults in the United States, is an autoimmune disorder — a condition in which the body’s immune system attacks healthy tissues. Its symptoms include...

UC Riverside mouse study finds paternal exposure to phthalates increases risk of metabolic diseases in progeny

Study provides insights into fighting broad range of pathogen’s viral strains

UC Riverside experts discuss disease symptoms, vaccines, and anxiety management

UC Riverside vaccine expert David Lo shares his thoughts in a Q&A

SAVE focuses on mutations in SARS-CoV-2 and emerging virus variants

UC Riverside’s Dr. David Lo, a vaccine expert, shares his thoughts

UC Riverside-led study shows how an effective therapy against SARS-CoV-2 could be developed

New method developed by UC Riverside researchers quickly assesses drug potential for rare disorders

Joint effort by UC Riverside and UCLA scientists aims to stop the COVID-19-spreading virus from attacking immune cells

UC Riverside-led team identifies a new host protein interaction that produces a robust immune response to viral infection in birds and may lead to better poultry vaccines

As the COVID-19 pandemic continues, the development of antiviral drug treatments has become a critical weapon in our arsenal against the virus. Harnessing the research and scientific brainpower needed to treat and prevent the next pandemic is the University of California - National Labs Antiviral Treatments Targeting All Coronaviruses and...